Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM

E

The Medicines Safety Agency Warns About Cold Treatments - Paris

Illustration of boxes of Humex, Rhinadvil, Actifed and Dolirhume medicines in a Paris pharmacy on October 23, 2023. The French Drug Safety Agency warns about cold treatments. Infarctions and strokes can occur after using these pseudoephedrine-based vasoconstrictors, designed to relieve cold symptoms. The risk is low, but sufficient to advise against their prescription. Photo by Tomas Stevens/ABACAPRESS.COM